✦ LIBER ✦

Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase

✍ Scribed by Sack, John S. ;Kish, Kevin F. ;Pokross, Matthew ;Xie, Dianlin ;Duke, Gerald J. ;Tredup, Jeffrey A. ;Kiefer, Susan E. ;Newitt, John A.

Publisher: International Union of Crystallography
Year: 2008
Tongue: English
Weight: 635 KB
Volume: 64
Category: Article
ISSN: 0907-4449
DOI: 10.1107/s0907444908010032

No coin nor oath required. For personal study only.

✦ Synopsis

The crystal structure of unphosphorylated p38 MAP kinase complexed with a representative pyrrolotriazine-based inhibitor led to the elucidation of the high-affinity binding mode of this class of compounds at the ATP-binding site. The ligand binds in an extended conformation, with one end interacting with the adenine-pocket hinge region, including a hydrogen bond from the carboxyl O atom of Met109. The other end of the ligand interacts with the hydrophobic pocket of the binding site and with the backbone N atom of Asp168 in the DFG activation loop. Addition of an extended benzylmorpholine group forces the DFG loop to flip out of position and allows the ligand to make additional interactions with the protein.

📜 SIMILAR VOLUMES

Structural basis for the binding of high

Structural basis for the binding of high affinity phosphopeptides to Stat3

✍ John S. McMurray 📂 Article 📅 2007 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 451 KB

## Abstract Signal transducer and activator of transcription 3 (Stat3) is constitutively active in a number of cancers where it participates in aberrant transcription of prosurvival, cell cycling, and angiogenesis genes. Since Stat3 initiates its signaling activity through binding of its SH2 domain

Synthesis of Imidazo[2, 1-a]phthalazines

Synthesis of Imidazo[2, 1-a]phthalazines, Potential Inhibitors of p38 MAP Kinase. Prediction of Binding Affinities of Protein Ligands

✍ Sylvie Mavel; Isabelle Thery; Alain Gueiffier 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 2 views

A Novel Series of p38 MAP Kinase Inhibit

A Novel Series of p38 MAP Kinase Inhibitors for the Potential Treatment of Rheumatoid Arthritis.

✍ Dearg S. Brown; Andrew J. Belfield; George R. Brown; Douglas Campbell; Alan Foub 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 13 KB 👁 2 views

ChemInform Abstract: Synthesis of Imidaz

ChemInform Abstract: Synthesis of Imidazo[2,1-a]phthalazines, Potential Inhibitors of p38 MAP Kinase. Prediction of Binding Affinities of Protein Ligands.

✍ Sylvie Mavel; Isabelle Thery; Alain Gueiffier 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 2 views

Structural basis for the activity of pp6

Structural basis for the activity of pp60c-src protein tyrosine kinase inhibitors

✍ Ninad V. Prabhu; Subeeh A. Siddiqui; John S. McMurray; B. Montgomery Pettitt 📂 Article 📅 2001 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 444 KB 👁 2 views

Conformational searches on three closely related pp60 c-src protein tyrosine kinase inhibitors of varying potencies were performed to determine a structural basis for their activity. The first was a linear peptide (PDNEYAFFQf), the second its 10-membered cyclic analogue, and the third a cyclic analo

X-ray crystal structure of JNK2 complexe

X-ray crystal structure of JNK2 complexed with the p38α inhibitor BIRB796: Insights into the rational design of DFG-out binding MAP kinase inhibitors

✍ Andreas Kuglstatter; Manjiri Ghate; Stan Tsing; Armando G. Villaseñor; David Sha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 669 KB

JNK2 and p38a are closely related mitogen-activated protein kinases that regulate various cellular activities and are considered drug targets for inflammatory diseases. We have determined the X-ray crystal structure of the clinical phase II p38a inhibitor BIRB796 bound to its off-target JNK2. This s